BSE Live
Dec 26, 16:01Prev. Close
2194.25
Open Price
2195.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:55Prev. Close
2193.30
Open Price
2206.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2193.00 (238)
| Balance Sheet of Mankind Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 10 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 20.03 | 20.03 | 20.03 | 20.03 | 14.84 | |
| Total Share Capital | 20.03 | 20.03 | 20.03 | 20.03 | 14.84 | |
| Reserves and Surplus | 1,938.62 | 1,535.47 | 1,191.26 | 900.69 | 485.00 | |
| Total Reserves and Surplus | 1,938.62 | 1,535.47 | 1,191.26 | 900.69 | 485.00 | |
| Total Shareholders Funds | 1,958.65 | 1,555.50 | 1,211.29 | 920.72 | 499.84 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.04 | 0.00 | 0.00 | 0.00 | 3.71 | |
| Deferred Tax Liabilities [Net] | 0.29 | 4.45 | 6.11 | 6.40 | 2.07 | |
| Other Long Term Liabilities | 23.41 | 22.07 | 21.27 | 20.11 | 0.00 | |
| Long Term Provisions | 9.88 | 4.84 | 2.08 | 1.98 | 0.00 | |
| Total Non-Current Liabilities | 33.62 | 31.36 | 29.46 | 28.49 | 5.78 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 193.61 | 175.79 | 149.57 | 203.89 | 0.00 | |
| Other Current Liabilities | 112.56 | 108.74 | 65.19 | 51.51 | 154.26 | |
| Short Term Provisions | 468.21 | 309.42 | 325.58 | 219.13 | 78.99 | |
| Total Current Liabilities | 774.38 | 593.98 | 540.34 | 474.53 | 233.24 | |
| Total Capital And Liabilities | 2,766.65 | 2,180.84 | 1,781.09 | 1,423.74 | 738.86 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 216.64 | 195.37 | 190.95 | 166.52 | 84.62 | |
| Intangible Assets | 4.91 | 7.31 | 11.60 | 11.20 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 7.30 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 265.94 | 224.06 | 208.99 | 178.15 | 91.92 | |
| Non-Current Investments | 256.01 | 109.51 | 87.66 | 27.01 | 156.42 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 200.99 | 218.84 | 167.59 | 110.92 | 0.00 | |
| Other Non-Current Assets | 181.56 | 16.05 | 64.77 | 67.05 | 0.00 | |
| Total Non-Current Assets | 904.50 | 568.46 | 529.02 | 383.14 | 248.34 | |
| CURRENT ASSETS | ||||||
| Current Investments | 688.47 | 689.05 | 350.46 | 149.15 | 0.00 | |
| Inventories | 436.41 | 337.19 | 312.67 | 361.73 | 153.55 | |
| Trade Receivables | 169.01 | 131.59 | 112.41 | 141.39 | 93.30 | |
| Cash And Cash Equivalents | 26.73 | 99.96 | 104.51 | 89.15 | 99.55 | |
| Short Term Loans And Advances | 541.53 | 354.58 | 372.02 | 299.18 | 144.12 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 1,862.15 | 1,612.38 | 1,252.07 | 1,040.60 | 490.52 | |
| Total Assets | 2,766.65 | 2,180.84 | 1,781.09 | 1,423.74 | 738.86 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 2.43 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.02 | 9.66 | 1.18 | 0.00 | 0.69 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 2.12 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 4.94 | 3.81 | 2.64 | 1.56 | 8.59 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 90.62 | 3.71 | 2.16 | 0.74 | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.19 | 5.19 | 5.19 | 5.19 | 4.05 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | 7.01 | 9.01 | 6.29 | 152.79 | |
| Non-Current Investments Unquoted Book Value | 256.01 | 102.50 | 80.11 | 20.35 | 3.65 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 731.40 | 694.23 | 353.39 | 149.70 | -- | |
| Current Investments Unquoted Book Value | 2.41 | -- | -- | -- | -- |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y